ZyVersa Therapeutics, Inc. (ZVSA)

NASDAQ: ZVSA · IEX Real-Time Price · USD

0.588

-0.048 (-7.55%)

At close: Apr 16, 2024, 3:49 PM

0.576

-0.012 (-1.96%)

After-hours: Apr 16, 2024, 5:39 PM EDT

ZyVersa Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Selling, General & Admin	11.21	7.61	5.58	5.36
Research & Development	3.21	5.41	2.12	6.47
Other Operating Expenses	93.33	0	0	0
Operating Expenses	107.75	13.01	7.7	11.83
Operating Income	-107.75	-13.01	-7.7	-11.83
Interest Expense / Income	-0	0.43	0.82	0.52
Other Expense / Income	-	0.61	-0.44	0.33
Pretax Income	-107.75	-14.05	-8.08	-12.68
Income Tax	-9.46	0	0	0
Net Income	-98.3	-14.05	-8.08	-12.68
Preferred Dividends	7.95	10.02	0	0
Net Income Common	-106.25	-24.06	-8.08	-12.68
Shares Outstanding (Basic)	1	24	1	1
Shares Outstanding (Diluted)	1	24	1	1
Shares Change	-95.97%	3403.91%	2.25%	-
EPS (Basic)	-108.97	-0.99	-11.55	-18.90
EPS (Diluted)	-108.97	-0.99	-11.55	-18.90
Free Cash Flow	-8.72	-1.49	-5.08	-5.11
Free Cash Flow Per Share	-8.94	-0.06	-7.35	-7.57
EBITDA	-107.74	-13.61	-7.25	-12.16
Depreciation & Amortization	0.01	0.01	0.01	0.01
EBIT	-107.75	-13.62	-7.26	-12.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).